Robert Christie — Billing Profile & Reimbursement Data
NPI 1922063437 · Arlington, VA · Hematology & Oncology Physician
Customize your policy alerts
Sign up for Robert Christie — Billing Profile & Reimbursement Data policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Robert Christie is a hematology & oncology physician provider located in Arlington, Virginia. This profile covers 59 Medicare and 0 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Robert Christie |
| Address | 1100 N Glebe Rd Ste 1600 |
| City | Arlington |
| State | VA |
| ZIP | 22201 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | April 18, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $885.7K |
| Medicaid | $0 |
Medicare: Total Revenue Breakdown by CPT/HCPCS Code
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
Medicare: Complete Services Breakdown
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
59 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 7,380 | $40 | $273.1K |
| J9271 | Injection, pembrolizumab, 1 mg | 5,300 | $40 | $227.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 870 | $70 | $64K |
| J0897 | Injection, denosumab, 1 mg | 3,480 | $20 | $62.6K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,400 | $30 | $46.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 250 | $110 | $27.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 180 | $120 | $22.1K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 12,000 | $1 | $12K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 5,200 | $1 | $10.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $130 | $9.5K |
Showing 1–10 of 59
Medicare: Competitive Analysis & Benchmarks
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 59 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
59 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 103 | 110 | 12,800 | $40 | $610.9K |
| J9144 | 32 | 60 | 8,280 | $40 | $332.7K |
| J0897 | 137 | 340 | 2,820 | $20 | $89.3K |
| J1568 | 31 | 30 | 1,990 | $30 | $81.8K |
| J0881 | 65 | 80 | 10,200 | $1 | $34.5K |
| J1439 | 49 | 50 | 29,250 | $1 | $30.5K |
| 96413 | 143 | 230 | 250 | $100 | $28.5K |
| J9217 | 110 | 130 | 140 | $130 | $23.9K |
| 99214 | 4,291 | 12,890 | 140 | $80 | $21K |
| J3490 | 90 | 110 | 60 | $280 | $20.5K |
Showing 1–10 of 59
Nearby Providers
Other providers in the same ZIP code as Robert Christie, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Healthqare Services Asc LLC | VA | Ambulatory Surgical Clinic/Center | $3.9M | $649.8K |
| Arlington County Government Department Of Managment & Finance | VA | Ambulance | $1.3M | $1.5M |
| Isabelle Le | VA | Hematology & Oncology Physician | $1M | $0 |
| Patricia Rodriguez | VA | Hematology & Oncology Physician | $989.1K | $0 |
| John Feigert | VA | Hematology & Oncology Physician | $925.9K | $0 |
| Keeran Sampat | VA | Hematology & Oncology Physician | $848.7K | $0 |
| Raymond Vlacancich | VA | Cardiovascular Disease Physician | $644.3K | $0 |
| Antonio Parente | VA | Cardiovascular Disease Physician | $317.1K | $0 |
| Thomas Raggio | VA | Vascular & Interventional Radiology Physician | $245.8K | $0 |
| Christopher Mcmanus | VA | Internal Medicine Physician | $102.1K | $0 |
Frequently Asked Questions
References
- 1.Medicare Physician & Other Practitioner by Provider and Service. CMS.gov.Provider-level Medicare Part B utilization and payment data.
- 2.NPPES NPI Registry. CMS.gov.National Provider Identifier registry used for provider enumeration and taxonomy metadata.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.